ATE68343T1 - Darreichungsform mit kontrollierter freigabe. - Google Patents

Darreichungsform mit kontrollierter freigabe.

Info

Publication number
ATE68343T1
ATE68343T1 AT88310271T AT88310271T ATE68343T1 AT E68343 T1 ATE68343 T1 AT E68343T1 AT 88310271 T AT88310271 T AT 88310271T AT 88310271 T AT88310271 T AT 88310271T AT E68343 T1 ATE68343 T1 AT E68343T1
Authority
AT
Austria
Prior art keywords
controlled release
medicament
release pharmaceutical
pharmaceutical form
coating layer
Prior art date
Application number
AT88310271T
Other languages
English (en)
Inventor
Masayoshi Samejima
Kazuo Noda
Masao Kobayashi
Shigeyuki Ishikawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE68343T1 publication Critical patent/ATE68343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88310271T 1987-11-06 1988-11-01 Darreichungsform mit kontrollierter freigabe. ATE68343T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28118987 1987-11-06
EP88310271A EP0315414B1 (de) 1987-11-06 1988-11-01 Darreichungsform mit kontrollierter Freigabe

Publications (1)

Publication Number Publication Date
ATE68343T1 true ATE68343T1 (de) 1991-11-15

Family

ID=17635585

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88310271T ATE68343T1 (de) 1987-11-06 1988-11-01 Darreichungsform mit kontrollierter freigabe.

Country Status (24)

Country Link
US (1) US4963365A (de)
EP (1) EP0315414B1 (de)
KR (1) KR940002655B1 (de)
CN (1) CN1035099C (de)
AT (1) ATE68343T1 (de)
AU (1) AU610275B2 (de)
BG (1) BG60638B1 (de)
CA (1) CA1331565C (de)
DE (1) DE3865631D1 (de)
DK (1) DK175249B1 (de)
ES (1) ES2027013T3 (de)
FI (1) FI96273C (de)
FR (1) FR2622799B1 (de)
GR (1) GR3002915T3 (de)
HK (1) HK44593A (de)
HU (1) HU201468B (de)
IE (1) IE60785B1 (de)
IL (1) IL88083A (de)
NO (1) NO176233C (de)
PH (1) PH25905A (de)
PT (1) PT88945B (de)
RU (1) RU1816213C (de)
SG (1) SG15493G (de)
ZA (1) ZA888147B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
DE59000232D1 (de) * 1989-02-11 1992-09-10 Bayer Ag Arzneimittel mit kontrollierter wirkstoffabgabe.
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
DE69028971T2 (de) * 1989-03-22 1997-05-22 Pang Peter K T Hypertensiver faktor des parathyroids
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
ATE120089T1 (de) * 1991-05-20 1995-04-15 Marion Laboratories Inc Mehrschichtige zubereitung mit kontrollierter freisetzung.
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
EP0571973B1 (de) * 1992-05-29 2000-02-02 Nikken Chemicals Co., Ltd. Tablette zur langsamen Freisetzung von Natriumvalproat
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
TW477708B (en) * 1996-09-13 2002-03-01 Shionogi & Amp Co Use of the thermal change to produce a substained release preparations and a process for their production
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
WO2000009133A1 (en) 1998-08-10 2000-02-24 Asahi Kasei Kogyo Kabushiki Kaisha Sustained release oral preparations of fasudil hydrochloride
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
CA2444569C (en) 2001-04-18 2011-01-04 Nostrum Pharmaceuticals Inc. A novel coating for a sustained release pharmaceutical composition
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
EP2112920B1 (de) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
CN1296046C (zh) * 2003-12-23 2007-01-24 广州市医药工业研究所 盐酸地尔硫䓬控释胶囊剂及其制备方法
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US8088414B2 (en) 2006-02-07 2012-01-03 Fmc Corporation Latex or pseudolatex compositions, coatings and coating processes
CA2648280C (en) 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8916588B2 (en) * 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) * 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) * 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
EP2529731A1 (de) * 2011-06-01 2012-12-05 Nitto Denko Corporation Partikelzubereitung und Herstellungsverfahren dafür
FR2996418B1 (fr) * 2012-10-09 2015-05-29 Seppic Sa Compositions alimentaires comprenant des capsules obtenues par coacervation ne mettant pas en œuvre de reticulant toxique
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857550A (en) * 1956-01-25 1960-12-29 Lowey Hans Improvements in or relating to the coating of shaped medical preparations
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
US4390406A (en) * 1982-07-23 1983-06-28 Allied Corporation Replaceable outer junction double junction reference electrode
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4851228A (en) * 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins

Also Published As

Publication number Publication date
RU1816213C (ru) 1993-05-15
FI885101A0 (fi) 1988-11-04
NO176233B (no) 1994-11-21
DK175249B1 (da) 2004-07-19
FI96273C (fi) 1996-06-10
HUT50624A (en) 1990-03-28
SG15493G (en) 1993-04-16
NO176233C (no) 1995-03-01
CN1035099C (zh) 1997-06-11
NO884947L (no) 1989-05-08
DK618088A (da) 1989-05-07
KR940002655B1 (ko) 1994-03-28
EP0315414B1 (de) 1991-10-16
AU610275B2 (en) 1991-05-16
NO884947D0 (no) 1988-11-04
IL88083A0 (en) 1989-06-30
PT88945A (pt) 1989-11-30
CN1033007A (zh) 1989-05-24
FI96273B (fi) 1996-02-29
IE60785B1 (en) 1994-08-10
ZA888147B (en) 1990-06-27
HU201468B (en) 1990-11-28
FR2622799A1 (fr) 1989-05-12
EP0315414A1 (de) 1989-05-10
AU2472788A (en) 1989-05-11
IL88083A (en) 1992-11-15
PH25905A (en) 1991-12-19
ES2027013T3 (es) 1992-05-16
IE883246L (en) 1989-05-06
GR3002915T3 (en) 1993-01-25
US4963365A (en) 1990-10-16
DE3865631D1 (de) 1991-11-21
KR890007720A (ko) 1989-07-05
FI885101A (fi) 1989-05-07
PT88945B (pt) 1993-05-31
BG85941A (bg) 1993-12-24
BG60638B1 (bg) 1995-11-30
CA1331565C (en) 1994-08-23
HK44593A (en) 1993-05-14
FR2622799B1 (fr) 1991-11-29
DK618088D0 (da) 1988-11-04

Similar Documents

Publication Publication Date Title
ATE68343T1 (de) Darreichungsform mit kontrollierter freigabe.
NO891052L (no) Farmaseutisk produkt for styrt avgivelse.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE68915291D1 (de) Verschlusskörpr zur verabreichung einer physiologisch aktiven substanz.
NO874960D0 (no) Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff.
NO904754L (no) Kapsel for innkapsling av biologisk aktive materialer, fremgangsmaate for fremstilling av denne, samt anvendelse derav.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
NO882406L (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
SE8701479D0 (sv) Metod for inneslutning av biologiskt verksamma preparat samt anvendning derav
NO883750L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
ATA214588A (de) Pharmazeutische dosierungsform zur kontrollierten abgabe von diltiazem
NO167287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-isoxazol-beta-carboliner.
NO170086C (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener
ATE8460T1 (de) Pharmazeutische praeparate und deren herstellung.
MY103627A (en) A controlled release pharmaceutical dosage form and a process for preparing same.
LV5394A3 (lv) Panemiens arstniecibas lidzekla iegusanai ar regulejamu aktivas vielas izdalisanos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time